Tag: American Academy of Neurology

  • Nation & World

    Slowing ALS symptom progression

    Harvard researchers find that treatment with dexpramipexole — a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell’s energy — appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS).

    4 minutes